Sviatlana Starchenka

Sviatlana Starchenka is an experienced professional in the field of pharmaceutical and biomedical sciences, currently serving as the Method Development Technical Lead and Technical Writer at Allergy Therapeutics since August 2012. Key responsibilities include bioanalytical method development and validation, ensuring compliance with GMP/GLP requirements and FDA/ICH guidelines, and providing technical expertise to various departments. Previously, Sviatlana held positions as a Senior QC Scientist, conducting biochemical and immunological testing to assure the quality of vaccine formulations, and as a research scientist at GlaxoSmithKline, focusing on histone demethylase expression and in vitro compound screening. Sviatlana’s academic qualifications include a Master of Research in Pharmaceutical and Biomedical Sciences and multiple degrees in Biomedical Science and Immunology from recognized institutions.